Home » Topics » BioWorld Science

BioWorld Science
RSS

MGH reports progress in development of a novel gene-based COVID-19 vaccine

May 8, 2020

Positive preclinical data support IND application for CardiALLO therapy in heart failure

May 8, 2020

FDA approves IND for Organicell Flow as treatment of SARS due to COVID-19

May 8, 2020

Cabo as next annual shot?

May 8, 2020

Antibiotics affect oxycodone effects

May 8, 2020

FDA clears new phase I study of NBTXR-3 activated by radiation therapy for pancreatic cancer

May 7, 2020

FDA approves Tabrecta for metastatic NSCLC with METex14

May 7, 2020

Enanta reports topline phase II data on EDP-305 in primary biliary cholangitis

May 7, 2020

FDA approves Elyxyb for acute treatment of migraine with or without aura

May 7, 2020

Lineage Cell Therapeutics updates phase I/IIa results with OpRegen for dry AMD

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...